Ws Management Lllp Solid Biosciences Inc. Transaction History

Ws Management Lllp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$7.19 - $32.37 $346,788 - $1.56 Million	-48,232 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$21.32 - $46.34 $670,684 - $1.46 Million	-31,458 Reduced 39.48%	48,232 $1.29 Million
Q2 2018 Aug 13, 2018	BUY	$7.33 - $43.15 $584,127 - $3.44 Million	79,690 New	79,690 $2.84 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $50.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.